CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancerYu Yan, Vanessa F. Merino, Guannan Wang et al.|Oncogene|2021Cited by 13
A side-by-side evaluation of [18F]FDOPA enantiomers for non-invasive detection of neuroendocrine tumors by positron emission tomographyAthira Narayan, Babak Behnam Azad, Yu Yan et al.|Oncotarget|2019Cited by 9
CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancerYu Yan, Vanessa F. Merino, Athira Narayan et al.|Research Square|2025Cited by 0